de Carvalho Augusto Ronaldo, Mello Silva Clélia Christina
Laboratory of Ecology and Evolution of Interactions 2EI, University Perpignan Via Domitia, IHPE UMR 5244, CNRS, IFREMER, Univ. Montpellier, 66860 Perpignan, France.
Laboratório de Avaliação e Promoção e Saúde Ambiental, Oswaldo Cruz Institute, Rio de Janeiro 21040-360, Brazil.
Vet Sci. 2018 Nov 6;5(4):94. doi: 10.3390/vetsci5040094.
Worldwide schistosomiasis remains a serious public health problem with approximately 67 million people infected and 200 million at risk of infection from inhabiting or transiting endemically active regions. Africa, South America, the Caribbean, and the Middle East are the main transmission regions of . The fight against transmission through the use of molluscicides is not recent and has been advocated as the only activity with the possibility of interruption of transmission in small, epidemiologically active outbreaks. var. (syn. ) (Des Moulins, 1826) is the most promising for use in official schistosomiasis control programs according to the WHO. In this review, we show that an understanding of some how latex affects the snail vector and their parasites from a molecular level to field conditions is lacking. On the other hand, this type of treatment could also provide a rationale for the control of schistosomiasis and other parasitosis. Several publications contribute to enforcing the use of latex in endemic countries as a cheap alternative or complement to mass drug treatment with praziquantel, the only available drug to cure the patients (without preventing re-infection).
全球范围内,血吸虫病仍然是一个严重的公共卫生问题,约有6700万人感染,2亿人因居住或途经血吸虫病流行活跃地区而面临感染风险。非洲、南美洲、加勒比地区和中东是主要的传播地区。通过使用杀螺剂来防治传播的做法由来已久,并且一直被倡导为在小规模、具有流行病学活性的疫情中唯一有可能中断传播的活动。根据世界卫生组织的说法,曼氏血吸虫(同义词:埃及血吸虫)(Des Moulins,1826年)是官方血吸虫病控制项目中最有希望使用的药物。在本综述中,我们表明,目前缺乏从分子水平到实地条件等方面对曼氏血吸虫乳胶如何影响钉螺宿主及其寄生虫的了解。另一方面,这种治疗方式也可以为血吸虫病和其他寄生虫病的防治提供理论依据。一些出版物促使血吸虫病流行国家使用曼氏血吸虫乳胶,作为吡喹酮大规模药物治疗(唯一可用于治疗患者的药物,不能预防再次感染)的一种廉价替代或补充方法。